CytRx Corp
CYTR
CYTR was delisted on the 3rd of June, 2019.
33 hedge funds and large institutions have $2.9M invested in CytRx Corp in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 19 closing their positions.
82% more call options, than puts
Call options by funds: $155K | Put options by funds: $85K
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
1.25% less ownership
Funds ownership: 7.47% → 6.22% (-1.2%)
30% less funds holding
Funds holding: 47 → 33 (-14)
43% less capital invested
Capital invested by funds: $5.08M → $2.9M (-$2.17M)
74% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$41.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$10.7K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$6.57K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$4.65K |
| 5 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
+$3.52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$526K |
| 2 |
Millennium Management
New York
|
-$86.3K |
| 3 |
Bank of New York Mellon
New York
|
-$29K |
| 4 |
State Street
Boston,
Massachusetts
|
-$24K |
| 5 |
Goldman Sachs
New York
|
-$15K |
CYTR Hedge Fund Activity: Q4 2017 in Review
33 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in CytRx Corp (CYTR) for Q4 2017, worth a combined $2.9M — down 43% from $5.08M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of CYTR and 5 opened new positions — a net loss of 14 holders — while 10 trimmed existing stakes and 13 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $41.6K. The largest seller was Vanguard Group, cutting an estimated $526K.
- 33 institutional investors held CytRx Corp (CYTR) as of Q4 2017, down from 47 in Q3 2017.
- Funds reported $2.9M of CytRx Corp stock for Q4 2017, down 43% quarter-over-quarter.
- 5 funds opened new CytRx Corp positions in Q4 2017 and 19 closed out, a net change of -14 holders.
- The largest CytRx Corp buyer in Q4 2017 was Citadel Advisors, an estimated $41.6K added.
- The largest CytRx Corp seller in Q4 2017 was Vanguard Group, an estimated $526K sold.
Based on aggregated 13F filings for Q4 2017.